WO2002069913A1 - Skin-improving composition set - Google Patents

Skin-improving composition set Download PDF

Info

Publication number
WO2002069913A1
WO2002069913A1 PCT/JP2001/001595 JP0101595W WO02069913A1 WO 2002069913 A1 WO2002069913 A1 WO 2002069913A1 JP 0101595 W JP0101595 W JP 0101595W WO 02069913 A1 WO02069913 A1 WO 02069913A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
skin
acid
agent
weight
Prior art date
Application number
PCT/JP2001/001595
Other languages
French (fr)
Japanese (ja)
Inventor
Sakae Shinkai
Original Assignee
Clinical Cosmetic Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Cosmetic Co., Ltd. filed Critical Clinical Cosmetic Co., Ltd.
Priority to JP2002569091A priority Critical patent/JPWO2002069913A1/en
Priority to PCT/JP2001/001595 priority patent/WO2002069913A1/en
Publication of WO2002069913A1 publication Critical patent/WO2002069913A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits

Definitions

  • the present invention relates to a composition set for improving skin.
  • the outermost epidermis of human skin is reborn in about 28 days by metabolism.
  • the newly born skin cells which become the epidermis, gradually rise to the surface of the skin while changing the shape in the form of a scrum, and then come off as dirt about 28 days later. I have. Therefore, as long as this metabolism is performed normally, the skin will always remain fresh.
  • Shin Chen Window is a force that keeps itself healthy by changing its rhythm and tempo and disturbing the scrum of cells as it gets older, that is, homeostasis (homeostasis). Will break. The collapse of the homeostasis causes dullness and spots on the skin, and the skin becomes dry and rough.
  • liquid preparations containing fruit acids (fruit acids) such as succinic acid, malic acid, citric acid, lactic acid, glycolic acid and tartaric acid, which are one kind of ⁇ -hydroxy acids (having carboxy and hydroxyl groups), as active ingredients
  • fruit acids such as succinic acid, malic acid, citric acid, lactic acid, glycolic acid and tartaric acid, which are one kind of ⁇ -hydroxy acids (having carboxy and hydroxyl groups)
  • ⁇ -hydroxy acids having carboxy and hydroxyl groups
  • a-hydroxy acid has the effect of exfoliating the stratum corneum, promoting cell regeneration, and whitening.
  • the present invention can be used without discomfort even when the content of ⁇ -hydroxy acid is increased, and furthermore, the metabolic function is assisted without damaging the skin, and the skin is kept beautiful and fresh.
  • the purpose of the present invention is to provide a composition set for improving skin that can be used. Disclosure of the invention
  • the composition set for skin improvement according to the present invention comprises at least one kind of amino acid, hyaluronate, water-soluble collagen, dipotassium glycyrrhizinate, allantoin, Elastin and at least
  • An agent comprising at least one plant extract as its active ingredient, an agent comprising at least one ⁇ -hydroxy acid, allantoin and dipotassium glycyrrhizinate as an active ingredient, a ceramide and
  • the composition was composed of three compositions of the agent C containing at least one plant extract as at least its active ingredient.
  • the amino acid in the preparation is not particularly limited, but as described in Claim 2, at least one selected from the group consisting of glycine, alanine, proline, serine, threonine, arginine, lysine, and glutamic acid. It is preferable to use
  • the plant extract in Agent A is not particularly limited.
  • the monohydroxy acid contained in the agent B is not particularly limited as contained in the agent C.
  • succinic acid, malic acid, citric acid, lactic acid, glycolic acid, tartaric acid It is preferable to use at least one selected from the group consisting of
  • the plant extract in the agent B is not particularly limited.
  • soybean extract, licorice extract, mulberry extract, cinnamon extract, natto extract, saxifrage extract, ⁇ wow / reshi flow extract It is preferable to use at least one selected from the group consisting of gonex and char extract.
  • agent C preferably contains at least a licorice extract as a plant extract, as described in claim 6.
  • the agent A is not particularly limited, but is preferably a geil type.
  • the concentration of amino acids in agent A is particularly high if it can penetrate pores, sweat, and the stratum corneum, and leave dirt, bacteria, cosmetics, and old keratin, etc., while leaving sebum, and lift it up.
  • it is preferably about 2% by weight to 5% by weight, more preferably 3% by weight to 4% by weight / 0 .
  • the B agent is usually a lotion type, but when it contains an oily active ingredient, suspended particles having a particle size of 300 ⁇ (preferably 100 ni) or less containing the oily active ingredient are contained. It may be a dispersed oil-in-water type emulsion.
  • the above-mentioned emulsion is not particularly limited.
  • it can be produced by using a known micro-emulsifier such as a high-pressure homogenizer.
  • the concentration of ⁇ - hydroxy acid in Agent B is not particularly limited, but is preferably about 4% by weight to 10% by weight, more preferably 7% by weight to 8% by weight, based on the total amount of Agent B. That is, if the concentration of the ⁇ -hydroxy acid is too low, the effect of adding the ⁇ -hydroxy acid is insufficient, and if the concentration is too high, the skin may be damaged.
  • ⁇ of the agent is not particularly limited, but is preferably about 4 to 6. That is, the lower the value of 11 is, the higher the effect of 0; If it is too low, it may be too irritating or cause skin damage.
  • the composition for skin improvement according to the present invention is composed of three types of compositions, A-agent, B-agent, and C-agent.
  • Agent A contains at least one amino acid, hyaluronate, water-soluble collagen, dipotassium glycyrrhizinate, allantoin, elastin, and at least one plant extract as at least active ingredients, The remainder is gelled mainly by purified water and a known thickener, and by adding a preservative and the like as necessary.
  • B agents alpha-hydroxy acids as malic acid, seed stone acid, lactic acid, in a total green cholate, comprising 7-8 wt 0/0 of the total, and further allantoin, at least as active ingredients and dipotassium glycyrrhizinate Included, the remainder is mainly purified water, and is a lotion type with ⁇ ⁇ 4 to 6 to which solvents such as alcohol and ⁇ ⁇ regulator are added as necessary.
  • Agent C is composed of ceramide, a small amount of ⁇ -hydroxy acid (malic acid, seed acid, lactic acid, and glycolic acid), sodium hyaluronate, water-soluble collagen, and complex plants (including at least licorice extract and shea extract) And as an active ingredient.
  • composition set for improving skin is used as follows.
  • composition set for skin improvement is configured as described above, and has the following effects.
  • a agent which contains amino acid as an active ingredient reacts with the water-soluble polymer by simply applying the agent to the skin, penetrates into pores, sweat, and the stratum corneum, and removes dirt such as dust, bacteria, cosmetics, and old dead skin while leaving sebum. Wrap it up and let it rise.
  • Agent B it is possible to clean the skin and help the permeation of the active ingredient in Agent B without rubbing the skin or damaging the skin by massaging.
  • the skin can be cleansed with sebum remaining, even if a B agent containing a high concentration of ct-hydroxy acid is applied to the skin, the skin feels less tingling and has excellent usability. There is no damage to them.
  • Agent A contains, in addition to amino acids, sodium hyaluronate, water-soluble collagen, strength D hydrolyzed elastin, dipotassium glycyrrhizinate, allantoin, and plant extract, so that it does not damage the skin and moisturizes it. can do. That is, sodium hyaluronate is a component that fills the space between the binding fibers and the cells of the skin, and has a strong water retention capacity to take the binding water between the cells and maintain the elasticity of the skin. It also has excellent moisturizing properties and keeps the skin smooth and soft.
  • Water-soluble collagen is a type of connective tissue protein present in the dermis of the skin. It forms a film on the skin and gives the skin moisture and flexibility with a high moisture effect.
  • Hydrolyzed elastin ( ⁇ -elastin) is a protein of connective tissue that exists in the dermis together with collagen, and is obtained by enzymatically decomposing elastin that is involved in the prevention of skin and tarmi. Improve elasticity and flexibility.
  • Dipotassium glycyrrhizinate is a component in extracts extracted from Chinese licorice and has anti-inflammatory and anti-allergic effects, and is effective against eczema and dermatitis.
  • Allantoin is a uric acid derivative contained in fin-filled grass, which has an astringent effect on the skin, removes dead wounds, cracks, eczema, etc., cleanses, promotes new tissue formation .
  • the plant extract has moisturizing, blood circulation promotion, anti-inflammation, capillary enhancement, anti-inflammatory effect and so on.
  • the agent contains a high concentration of ⁇ - hydroxy acid, which is composed of malic acid, tartaric acid, lactic acid, and dalycholic acid, it can effectively activate cells of damaged skin. Specifically, malic acid improves stains made with active oxygen. Tartaric acid keeps the skin in favor, reduces bacterial growth and makes the skin more resistant. Lactic acid works on skin keratin, softens skin, increases moisture retention, and protects skin from drying out. Glycolic acid proliferates fibroblasts in the dermis layer of the skin and improves the firmness of the skin.
  • ⁇ - hydroxy acid which is composed of malic acid, tartaric acid, lactic acid, and dalycholic acid
  • the application of the agent C which contains a large amount of vitamins and minerals and promotes metabolism as an active ingredient, is applied over the agent B, so that the metabolism is further promoted.
  • the licorice extract contained in the agent C is effective in detoxification and antiallergic effects, and can be used to improve atopic dermatitis.
  • the extract contained a large amount of vitamin C and amino acids. Exhibits astringent, antioxidant, and ultraviolet absorption properties.
  • a skin-improving thread set composed of agent C was prepared.
  • agent A to the face, wash the face with lukewarm water within 30 seconds, take agent B on the palm of your hand, apply lightly on the skin, and apply agent C after agent B is used.
  • the procedure of application is 3 people in their 20s (A to C), 5 people in their 30s (A to E), 9 people in their 40s (A to I), 5 people in their 50s (A to E), 5 in the 60s (A
  • composition for improving skin of the present invention comprising the three liquid preparations of A preparation, B preparation and C preparation is used, regardless of age, considerable skin improvement can be achieved in one month of use, regardless of age. The effect is seen, and it is clear that most people will have beautiful skin after 12 months.
  • the present invention is not limited to the above-described embodiments and examples, and that a vitamin supplement component, a fragrance, a solubilizer, a thickener, a humectant, a humectant, a solvent, and the like are contained in each composition.
  • Ingredients to be added to ordinary cosmetics can be appropriately added to such an extent that the function of the active ingredient is not hindered.
  • it goes without saying that it is diluted with purified water.
  • composition set for skin improvement according to the present invention is constituted as described above, it can be used without discomfort even if the concentration of o: -hydroxy acid is increased, and has a metabolic function without damaging the skin. Helps and keeps the skin beautiful and fresh.
  • content of the a-hydroxy acid can be increased, the improvement effect is enhanced and the improvement speed is also increased.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)

Abstract

A skin-improving composition set composed of three compositions including: an agent (A) containing, at least as the active ingredients, at least one amino acid, a hyaluronic acid salt, water-soluble collagen, dipotassium glycyrrhetinate, allantoin, hydrolyzed elastin solution and at least one plant extract; an agent (B) containing, at least as the active ingredients, at least one α-hydroxy acid, allantoin and dipotassium glycyrrhetinate; and an agent (C) containing, at least as the active ingredients, ceramide and at least one plant extract.

Description

明 細 書 皮膚改善用組成物セット 技術分野  Description Skin improvement composition set Technical field
本発明は、 皮膚改善用組成物セットに関する。 背景技術  The present invention relates to a composition set for improving skin. Background art
人間の皮膚の一番外側にある表皮は、 新陳代謝によって約 2 8日で生まれ変わ るようになっている。 すなわち、 新たに生まれた表皮となる皮膚細胞は、 スクラ ムを組んだ状態で形状を変えながら次第に皮膚の表面側に上がってきた後、 約 2 8日後に垢となってはがれ落ちるようになつている。 したがって、 この新陳代謝 が正常に行われている限り皮膚は常にみずみずしい状態を保つ。  The outermost epidermis of human skin is reborn in about 28 days by metabolism. In other words, the newly born skin cells, which become the epidermis, gradually rise to the surface of the skin while changing the shape in the form of a scrum, and then come off as dirt about 28 days later. I have. Therefore, as long as this metabolism is performed normally, the skin will always remain fresh.
ところで、 新陳代窗すは、 年齢を重ねるにつれて、 そのリズムやテンポが変化し たり、 細胞のスクラムが乱れたりして、 自らを健やかに保とうとする力、 すなわ ち、 ホメォスタシス (恒常性保持機能) を崩してしまう。 そして、 このホメォス タシスの崩れによって、 皮膚にくすみ、 シミが発生したり、 皮膚が乾燥してなど ガサガサの状態になったりする。  By the way, Shin Chen Window is a force that keeps itself healthy by changing its rhythm and tempo and disturbing the scrum of cells as it gets older, that is, homeostasis (homeostasis). Will break. The collapse of the homeostasis causes dullness and spots on the skin, and the skin becomes dry and rough.
そこで、 α—ヒドロキシ酸 (カルボキシ基とヒドロキシル基を持つ) の 1種で あるコハク酸、 リンゴ酸、 クェン酸、 乳酸、 グリコール酸、 酒石酸等のフルーツ 酸 (果実酸) を有効成分とする液剤や軟膏を塗布することによってホメォスタシ スの崩れを改善し、 皮膚の新陳代謝機能を正常化させて皮膚の乾燥やガサツキを なくすようにする皮膚改善用組成物が ¾に各種提案されている (特公平 2— 3 1 0 5 3号公報、 特開平 5 - 1 3 9 9 4 7号公報等)。  Therefore, liquid preparations containing fruit acids (fruit acids) such as succinic acid, malic acid, citric acid, lactic acid, glycolic acid and tartaric acid, which are one kind of α-hydroxy acids (having carboxy and hydroxyl groups), as active ingredients Various skin-improving compositions have been proposed in (1) to improve the collapse of homeostasis by applying an ointment, to normalize the metabolic function of the skin, and to eliminate dryness and rough skin. — Japanese Patent Application Laid-Open No. 31053/1995, Japanese Patent Application Laid-Open No. 5-1399747)
• すなわち、 a—ヒドロキシ酸が、 角質層の剥離効果、 細胞の再生促進といった 効果、 美白効果などがある。  • In other words, a-hydroxy acid has the effect of exfoliating the stratum corneum, promoting cell regeneration, and whitening.
ところで、 上記のような α—ヒドロキシ酸が有効成分として含まれた皮膚改善 用組成物を皮膚に塗布しょうとする場合、 まず、 石験やクレンジング剤を用いて 皮膚表面の汚れ等を取り除く必要があるが、 従来の石鹼ゃクレンジング剤では、 界面活性剤が含まれるので、 皮膚を保護する皮脂まで完全に洗い流してしまう。 したがって、 皮膚改善効果を上げるため、 《—ヒドロキシ酸の含有濃度をあげる と、 ピリピリするなどの違和感があるとともに、 ーヒドロキシ酸の効果を十分 には発揮させることができず、 却って皮膚を傷めてしまう恐れがある。 By the way, when applying a skin-improving composition containing an α-hydroxy acid as an active ingredient as described above to the skin, it is first necessary to remove dirt on the skin surface using a stone test or a cleansing agent. However, with conventional stone cleansing agents, Because it contains surfactants, it completely rinses away the sebum that protects the skin. Therefore, if the concentration of hydroxy acids is increased in order to improve the effect of improving the skin, discomfort such as tingling may occur, and the effects of hydroxy acids may not be fully exerted, and the skin may be damaged instead. There is fear.
本発明は、 以上のような事情に鑑みて、 α—ヒドロキシ酸の含有濃度を高くし ても違和感無く使用でき、 しかも、 皮膚を傷めることなく新陳代謝機能を助け、 皮膚を美しくみずみずしい状態に保つことができる皮膚改善用組成物セットを提 供することを目的としている。 発明の開示  In view of the circumstances described above, the present invention can be used without discomfort even when the content of α-hydroxy acid is increased, and furthermore, the metabolic function is assisted without damaging the skin, and the skin is kept beautiful and fresh. The purpose of the present invention is to provide a composition set for improving skin that can be used. Disclosure of the invention
このような目的を達成するために、本発明にかかる皮膚改善用組成物セットは、 少なくとも 1種のアミノ酸と、 ヒアルロン酸塩と、 水溶性コラーゲンと、 グリチ ルリチン酸ジカリウムと、 アラントインと、 加水分解エラスチンと、 少なくとも In order to achieve such an object, the composition set for skin improvement according to the present invention comprises at least one kind of amino acid, hyaluronate, water-soluble collagen, dipotassium glycyrrhizinate, allantoin, Elastin and at least
1種の植物抽出エキスとを、 少なくともその有効成分として含む Α剤、 少なくと も 1種の α—ヒドロキシ酸と、 アラントインと、 グリチルリチン酸ジカリウムと を、 少なくともその有効成分として含む Β剤、 セラミドと、 少なくとも 1種の植 物エキスとを、 少なくともその有効成分として含む C剤の 3つの組成物から構成 するようにした。 An agent comprising at least one plant extract as its active ingredient, an agent comprising at least one α-hydroxy acid, allantoin and dipotassium glycyrrhizinate as an active ingredient, a ceramide and However, the composition was composed of three compositions of the agent C containing at least one plant extract as at least its active ingredient.
Α剤中のアミノ酸としては、特に限定されないが、請求の範囲第 2項のように、 グリシン、 ァラニン、 プロリン、 セリン、 スレオニン、 アルギニン、 リジン、 グ ルタミン酸からなる群より選ばれた少なくとも 1種を用いることが好ましい。  The amino acid in the preparation is not particularly limited, but as described in Claim 2, at least one selected from the group consisting of glycine, alanine, proline, serine, threonine, arginine, lysine, and glutamic acid. It is preferable to use
A剤中の植物抽出エキスとしては、 特に限定されないが、 たとえば、 請求の範 囲第 3項のように、 ォゥゴンエキス、 センブリエキス、 アロエエキス、 カモミラ エキス、 才トギリソゥエキス、 シナノキエキス、 トウキンセン力エキスャグノレマ ソゥエキス、 ローマ力ミツレエキス、 ァノレ力二力エキス、 /、°リエタエキス、 キュ 一カンパエキス、 セィユキズタエキス、 ゼユアオイエキス、 セィヨウエワトコェ キス、 マツリ力エキス、 ドクダミエキス、 甘草エキス、 マロニエエキス、 コゥゾ エキス、 サルビアエキス、 三色スミレエキス、 スギナエキスからなる群より選ば れた少なくとも 1種を用いることが好ましい。 B剤中おょぴ C剤中に含まれる "一ヒドロキシ酸としては特に限定されないが、 たとえば、 請求の範囲第 4項のように、 コハク酸、 リンゴ酸、 クェン酸、 乳酸、 グリコール酸、 酒石酸からなる群より選ばれた少なくとも 1種を用いることが好 ましい。 The plant extract in Agent A is not particularly limited. Roman force beetle extract, anore force two force extract, /, ° rieta extract, kyucampa extract, seiyukizuta extract, zeyuaoi extract, seiyouwatokokisu, matsuri force extract, dokudami extract, licorice extract, malonier extract, kozozo extract, salvia It is preferable to use at least one selected from the group consisting of an extract, a three-color violet extract, and a horsetail extract. The monohydroxy acid contained in the agent B is not particularly limited as contained in the agent C. For example, as described in Claim 4, succinic acid, malic acid, citric acid, lactic acid, glycolic acid, tartaric acid It is preferable to use at least one selected from the group consisting of
B剤中の植物抽出エキスとしては、 特に限定されないが、 たとえば、 請求の範 囲第 5項のように、 ダイズエキス、 甘草エキス、 クヮエキス、 チヤエキス、 納豆 エキス、 ユキノシタエキス、 ゥワウ/レシ流エキス、 才ゥゴンエキス、 チヤエキス からなる群より選ばれた少なくとも 1種を用いることが好ましい。  The plant extract in the agent B is not particularly limited. For example, as described in claim 5, soybean extract, licorice extract, mulberry extract, cinnamon extract, natto extract, saxifrage extract, 、 wow / reshi flow extract, It is preferable to use at least one selected from the group consisting of gonex and char extract.
に、 C剤中には、 請求の範囲第 6項のように、 植物抽出エキスとして甘草ェ キスおょぴチヤエキスが少なくとも含まれていることが好ましい。  In addition, the agent C preferably contains at least a licorice extract as a plant extract, as described in claim 6.
A剤は、 特に限定されないが、 ジエルタイプのものが好ましい。 また、 A剤中 のアミノ酸の濃度は、 毛穴、 汗口、 角質層の中に入り込み、 皮脂を残した状態で ほこり、 細菌、 化粧品、 古い角質などの汚れを包み込んで浮き上がらせることが できれば、 特に限定されないが、 2重量%〜 5重量%程度が好ましく、 3重量% 〜4重量 °/0がより好ましい。 The agent A is not particularly limited, but is preferably a geil type. In addition, the concentration of amino acids in agent A is particularly high if it can penetrate pores, sweat, and the stratum corneum, and leave dirt, bacteria, cosmetics, and old keratin, etc., while leaving sebum, and lift it up. Although not limited, it is preferably about 2% by weight to 5% by weight, more preferably 3% by weight to 4% by weight / 0 .
B剤は、 通常ローションタイプのものが用いられるが、 油性の有効成分を含む 場合油性の有効成分が含まれた粒径 3 0 0 μ πι (好ましくは 1 0 0 ni) 以下の 懸濁粒子が分散された水中油滴型乳液状にとしても構わない。  The B agent is usually a lotion type, but when it contains an oily active ingredient, suspended particles having a particle size of 300 μππι (preferably 100 ni) or less containing the oily active ingredient are contained. It may be a dispersed oil-in-water type emulsion.
すなわち、 水溶性の成分の場合、 問題はないのであるが、 油性の成分の場合、 懸濁粒径が大きいと皮膚のラメラ構造の隙間を縫って皮膚内部まで有効成分が浸 透しにくく、 十分な効果を得られなくなる恐れがある。  In other words, there is no problem in the case of water-soluble components, but in the case of oil-based components, if the suspension particle size is large, it is difficult to penetrate the active ingredients into the skin by sewing through the gaps in the lamellar structure of the skin, May not be able to achieve the desired effect.
また、 上記のような乳化物は、 特に限定されないが、 たとえば、 高圧ホモジナ ィザ一等の公知のマイクロ乳化装置を用レ、て製造することができる。  Further, the above-mentioned emulsion is not particularly limited. For example, it can be produced by using a known micro-emulsifier such as a high-pressure homogenizer.
なお、 B剤中の α—ヒド キシ酸の濃度は、 特に限定されないが、 全 B剤中 4 重量%~ 1 0重量%程度が好ましく、 7重量%〜 8重量%がより好ましい。 すな わち、 α—ヒドロキシ酸の濃度が低過ぎると α—ヒドロキシ酸の添加効果があま りなく、 高過ぎると却って皮膚を傷めたりする恐れがある。 The concentration of α- hydroxy acid in Agent B is not particularly limited, but is preferably about 4% by weight to 10% by weight, more preferably 7% by weight to 8% by weight, based on the total amount of Agent B. That is, if the concentration of the α-hydroxy acid is too low, the effect of adding the α-hydroxy acid is insufficient, and if the concentration is too high, the skin may be damaged.
また、 Β剤の ρ Ηは、特に限定されないが、 4〜 6程度とすることが好ましい。 すなわち、 11が低ぃ程0;—ヒドロキシ酸の細胞活性効果が高まるのであるが、 低過ぎると刺激が強過ぎたり、 皮膚を却って傷めたりする恐れがある。 発明を実施するための最良の形態 Further, ρ} of the agent is not particularly limited, but is preferably about 4 to 6. That is, the lower the value of 11 is, the higher the effect of 0; If it is too low, it may be too irritating or cause skin damage. BEST MODE FOR CARRYING OUT THE INVENTION
以下に、 本発明の皮膚改善用組成物セットの実施の形態を詳しく説明する。 本発明の皮膚改善用,袓成物セットは、 A剤、 B剤、 C剤の 3種類の組成物から 構成されている。  Hereinafter, embodiments of the skin improving composition set of the present invention will be described in detail. The composition for skin improvement according to the present invention is composed of three types of compositions, A-agent, B-agent, and C-agent.
A剤は、 少なくとも 1種のアミノ酸と、 ヒアルロン酸塩と、.水溶性コラーゲン と、 グリチルリチン酸ジカリウムと、 アラントインと、 エラスチンと、 少なくと も 1種の植物抽出エキスとを少なくとも有効成分として含み、 残部が精製水およ ぴ公知の増粘剤を主体とし、 防腐剤等を必要に応じて添加することによってジェ ル化されている。  Agent A contains at least one amino acid, hyaluronate, water-soluble collagen, dipotassium glycyrrhizinate, allantoin, elastin, and at least one plant extract as at least active ingredients, The remainder is gelled mainly by purified water and a known thickener, and by adding a preservative and the like as necessary.
B剤は、 α—ヒドロキシ酸としてのりんご酸、 種石酸、 乳酸、 グリーコール酸 を合計で、 全体の 7〜8重量0 /0含み、 さらにアラントインと、 グリチルリチン酸 ジカリウムとを少なくとも有効成分として含み、 残部が精製水を主体とし、 アル コール等の溶剤、 ρ Η調整剤等を必要に応じて添加した ρ Η 4〜 6の口ーション タイプをしている。 B agents, alpha-hydroxy acids as malic acid, seed stone acid, lactic acid, in a total green cholate, comprising 7-8 wt 0/0 of the total, and further allantoin, at least as active ingredients and dipotassium glycyrrhizinate Included, the remainder is mainly purified water, and is a lotion type with ρ Η 4 to 6 to which solvents such as alcohol and ρ Η regulator are added as necessary.
C剤は、 セラミドと、 少量の α—ヒドロキシ酸 (りんご酸、 種石酸、 乳酸、 グ リーコール酸) と、 ヒアルロン酸ナトリウムと、 水溶性コラーゲンと、 複合植物 (甘草エキスおよびチヤエキスを少なくとも含む) とを有効成分として含んでい る。  Agent C is composed of ceramide, a small amount of α-hydroxy acid (malic acid, seed acid, lactic acid, and glycolic acid), sodium hyaluronate, water-soluble collagen, and complex plants (including at least licorice extract and shea extract) And as an active ingredient.
そして、 上記皮膚改善用組成物セットは、 以下のようにして使用するようにな つている。  The composition set for improving skin is used as follows.
( 1 ) Α剤を顔、 首筋、 耳、 手の甲などの皮膚に塗布し、 その上から皮膚を必要 に応じて軽くマッサージした後、 A剤を洗い流す。  (1) Apply the agent to the skin of the face, neck, ears, back of hands, etc., massage the skin lightly from above as needed, and then wash away agent A.
( 2 ) B剤を手の平にとり、 皮膚を軽くパッデイングするように塗布する。 (2) Take Agent B on the palm of your hand and apply lightly to the skin.
( 3 ) B剤が馴染んだらその上からさらに C剤を塗布する。 (3) If the B agent is used, apply the C agent on it.
上記皮膚改善用組成物セットは、 以上のようになつており、 以下のような効果 を備えている。  The above-mentioned composition set for skin improvement is configured as described above, and has the following effects.
アミノ酸を有効成分として含む A剤によってまず洗浄するようにしたので、 A 剤を皮膚に塗布するだけで、 アミノ酸が水溶性高分子と反応し、 毛穴、 汗口、 角 質層の中に入り込み、 皮脂を残した状態でほこり、 細菌、 化粧品、 古い角質など の汚れを包み込んで浮き上がらせる。 すなわち、 皮膚を強くこすったりマッサ一 ジして皮膚を傷めたりすることなく、 皮膚の汚れをきれいに落し、 B剤中の有効 成分の浸透を助けることができる。 しかも、 皮脂を残した状態で皮膚を清浄化で きるので、 その上から高い濃度の ctーヒドロキシ酸を含む B剤を皮膚に塗布して も、 ピリピリ感が少なく使用感に優れているとともに、 皮膚を傷めたりすること がない。 First, it was washed with A agent which contains amino acid as an active ingredient. The amino acid reacts with the water-soluble polymer by simply applying the agent to the skin, penetrates into pores, sweat, and the stratum corneum, and removes dirt such as dust, bacteria, cosmetics, and old dead skin while leaving sebum. Wrap it up and let it rise. In other words, it is possible to clean the skin and help the permeation of the active ingredient in Agent B without rubbing the skin or damaging the skin by massaging. Moreover, since the skin can be cleansed with sebum remaining, even if a B agent containing a high concentration of ct-hydroxy acid is applied to the skin, the skin feels less tingling and has excellent usability. There is no damage to them.
A剤が、 アミノ酸に加えて、 ヒアルロン酸ナトリウム、 水溶性コラーゲン、 力 D 水分解エラスチン、 グリチルリチン酸ジカリウム、 アラントイン、 植物抽出ェキ スを含んでいるので、 より皮膚を傷めず潤いのあるものにすることができる。 すなわち、 ヒアルロン酸ナトリウムは、 皮膚の結合繊維と細胞間を埋める成分 であって、保水力が強く細胞間で結合水をとり、皮膚の弾力性を維持する。また、 保湿作用にも優れ皮膚の滑らかさと柔軟性を保つ。  Agent A contains, in addition to amino acids, sodium hyaluronate, water-soluble collagen, strength D hydrolyzed elastin, dipotassium glycyrrhizinate, allantoin, and plant extract, so that it does not damage the skin and moisturizes it. can do. That is, sodium hyaluronate is a component that fills the space between the binding fibers and the cells of the skin, and has a strong water retention capacity to take the binding water between the cells and maintain the elasticity of the skin. It also has excellent moisturizing properties and keeps the skin smooth and soft.
水溶性コラーゲンは、皮膚の真皮に存在する結合組織の蛋白質の一種であって、 皮膚上に皮膜をつくり高いモイスチャー効果で皮膚に潤いと柔軟性を与える。 加水分解エラスチン (α—エラスチン) は、 コラーゲンとともに真皮に存在す る結合組織の蛋白質でシヮ、 タルミの防止に関与しているエラスチンを酵素分解 したものであって、 表皮に馴染み易く、 皮膚の弾力性や柔軟性を向上させる。 グリチルリチン酸ジカリウムは、 漢方の甘草からの抽出される抽出物中の成分 であって、 抗炎症作用、 抗アレルギー作用があり、 湿疹、 皮膚炎などに効果があ る。  Water-soluble collagen is a type of connective tissue protein present in the dermis of the skin. It forms a film on the skin and gives the skin moisture and flexibility with a high moisture effect. Hydrolyzed elastin (α-elastin) is a protein of connective tissue that exists in the dermis together with collagen, and is obtained by enzymatically decomposing elastin that is involved in the prevention of skin and tarmi. Improve elasticity and flexibility. Dipotassium glycyrrhizinate is a component in extracts extracted from Chinese licorice and has anti-inflammatory and anti-allergic effects, and is effective against eczema and dermatitis.
アラントインは、 ヒレハリ草中に含まれる尿酸誘導体であって、 皮膚の収斂作 用があり、 切創、 亀裂、 湿疹などの壌死,袓織を除去し、 清浄にし、 新しい組織形 成を促進する。  Allantoin is a uric acid derivative contained in fin-filled grass, which has an astringent effect on the skin, removes dead wounds, cracks, eczema, etc., cleanses, promotes new tissue formation .
植物抽出エキスは、 保湿、 血行促進、 消炎、 毛細血管強化、 抗炎症作用などを もたらす。  The plant extract has moisturizing, blood circulation promotion, anti-inflammation, capillary enhancement, anti-inflammatory effect and so on.
Β剤がりんご酸、 酒石酸、 乳酸、 ダリーコール酸からなる高濃度の α—ヒドロ キシ酸を含んでいるので、傷んだ皮膚の細胞の活性化を有効に図ることができる。 詳しく説明すると、 りんご酸が、 活性酸素などでつくられたシミを改善する。 酒 石酸が肌を賛成に保ち、 細菌の増殖を抑え肌に抵抗力を付ける。 乳酸が皮膚のケ ラチンに働き、 肌を柔軟にし水分保持能力を高め、 乾燥から肌を守る。 グリコー ル酸が、 皮膚の真皮層の繊維芽細胞を増殖し、 肌にハリをもたせたシヮを改善す る。 (4) Since the agent contains a high concentration of α- hydroxy acid, which is composed of malic acid, tartaric acid, lactic acid, and dalycholic acid, it can effectively activate cells of damaged skin. Specifically, malic acid improves stains made with active oxygen. Tartaric acid keeps the skin in favor, reduces bacterial growth and makes the skin more resistant. Lactic acid works on skin keratin, softens skin, increases moisture retention, and protects skin from drying out. Glycolic acid proliferates fibroblasts in the dermis layer of the skin and improves the firmness of the skin.
さらに、 B剤の上から、 ビタミン、 ミネラルなどを多く含み新陳代謝を促進す るセラミ ドを有効成分として含む C剤を塗布するようになっているので、 より新 陳代謝を促進する。 また、 C剤は、 含まれた甘草エキスが解毒'抗アレルギー作 用を発揮しアトピー性皮膚炎等の改善も図ることができるとともに、 含まれたチ ヤエキスがビタミン C ·アミノ酸を多く含んでおり収斂作用、 抗酸化作用、 紫外 線吸収作用を発揮する。 実施例  In addition, the application of the agent C, which contains a large amount of vitamins and minerals and promotes metabolism as an active ingredient, is applied over the agent B, so that the metabolism is further promoted. In addition, the licorice extract contained in the agent C is effective in detoxification and antiallergic effects, and can be used to improve atopic dermatitis.In addition, the extract contained a large amount of vitamin C and amino acids. Exhibits astringent, antioxidant, and ultraviolet absorption properties. Example
以下に、 本発明のより具体的な実施例を詳しく説明する。  Hereinafter, more specific examples of the present invention will be described in detail.
(実施例 1)  (Example 1)
以下の配合の有効成分を含むジエル状 A剤、 ローション状 B剤、 ローション状 Jiel A, Lotion B, Lotion containing the following active ingredients
C剤からなる皮膚改善用糸且成物セットを用意した。 A skin-improving thread set composed of agent C was prepared.
〔A剤の有効成分〕  (Active ingredient of agent A)
'アミノ酸' · ·約 3. 2重量%  'Amino acid' · Approx. 3.2% by weight
(内訳 L一プロブリン 0. 002重量%、 L一アルギニン 3. 15重量%、 グ リシン 0. 0001重量0 /0、 Lーァラニン 0. 00004重量0 /0、 L—セリン 0.(Breakdown L one Puroburin 0.002 wt%, L one-arginine 3.15 wt%, glycine 0.0001 wt 0/0, L Aranin 0.00004 wt 0/0, L-serine 0.
0001 5重量0 /0、 L—スレオニン 0. 00002重量%、 L—リジン 0. 00 007重量0 /0、 L -グルタミン酸 0. 000075重量0 /0) 0001 5 weight 0/0, L-threonine 0.00002 wt%, L-lysine 0.00 007 weight 0/0, L - glutamic 0.000075 wt 0/0)
' ヒアルロン酸ナトリウム · · · 0. 01重量0 /0 'Sodium hyaluronate - - - 0.01 weight 0/0
•水溶性コラーゲン . · · 0. 01重量%  • Water-soluble collagen 0.01% by weight
'グリチルリチン酸ジカリウム · · · 0. 0 :  'Dipotassium glycyrrhizinate0.0
'アラントイン ' · · 0. 01重量0 /0 'Allantoin' - - 0.01 weight 0/0
'加水分解エラスチン液' · · 0. 01重量%  'Hydrolyzed elastin solution' · · 0.01% by weight
'植物抽出エキス ' · · 0. 04重量% (内訳:ォゥゴンエキス 0. 01重量%、 センブリエキス 0. 01重量%、 了 ロエベラエキス 0. 01重量%、 アル力二エキス 0. 001667重量0 /0、 パリ エタエキス 0.001667重量0 /0、キューカンバエキス 0.001667重量0 /0、 セィユキズタエキス 0. 001667重量0 /0、 ゼニァオイエキス 0. 00166 7重量0 /0、 セィヨウニヮトコエキス 0. 001667重量%、) 'Plant extract' · · · 0.04% by weight (Breakdown: Ougon'ekisu 0.01% by weight, assembly extract 0.01% by weight, Ryo Roeberaekisu 0.01% by weight, Al force two extract 0.001667 weight 0/0, Paris Etaekisu 0.001667 weight 0/0, queue birch extract 0.001667 weight 0/0, Si Yu ivy extract 0.001667 wt 0/0, Zeniaoiekisu 0.00166 7 wt 0/0, Si iodide two Wa Toco extract 0.001667 wt%)
〔B剤の有効成分〕  (Active ingredient of agent B)
• α—ヒ ドロキシ酸' · · 7. 11重量0 /0 • α- human Dorokishi acid '- - 7.11 weight 0/0
(内訳: DL—りんご酸 0. 1重量%、 酒石酸 0. 01重量%、 グリコール酸 (Breakdown: DL-malic acid 0.1% by weight, tartaric acid 0.01% by weight, glycolic acid
3. 5重量%、 乳酸 3. 5重量%) (3.5% by weight, lactic acid 3.5% by weight)
·アラントイン · · · (). 01重量0 /0 - allantoin - - - (). 01 weight 0/0
•グリチルリチン酸ジカリウム ' · · 0. 1重量0 /0 • dipotassium glycyrrhizin acid '- - 0.1 weight 0/0
〔c剤の有効成分〕  (Active ingredient of agent c)
'セラミ ド . . · ο. 01重量0 /0 'Ceramide.. · Ο. 01 weight 0/0
•植物エキス . · · {). 08重量0 /0 • plant extracts. ... {). 08 weight 0/0
(内訳:甘草エキス 0, 01重量0 /0、 チヤエキス 0. 01重量%、 ダイズェキ ス 0. 01重量%、 ユキノシタエキス 0. 01重量%、 ゥワウルシ流エキス 0.(Breakdown: licorice extract 0, 01 weight 0/0, Chiyaekisu 0.01% by weight, Daizueki scan 0.01% by weight, saxifrage extract 0.01% by weight, Uwaurushi flow extract 0.
01重量0/。、 ォゥゴンエキス 0. 01重量%、 ォゥゴンエキス 0. 01重量%、 ソゥハクビエキス 0. 01重量0 /o) 01 weight 0 /. , Oregon extract 0.01% by weight, Ogon extract 0.011% by weight, Soybean extract 0.011 weight 0 / o)
• a—ヒ ドロキシ酸 · · · 0 · 04重量0 /0 • a- human Dorokishi acid - - - 0 - 04 weight 0/0
(内訳: DL—りんご酸 0. 01重量%、 酒石酸 0. 01重量%、 グリコール 酸 0. 01重量%、 乳酸 0. 01重量。/。)  (Breakdown: DL-malic acid 0.01% by weight, tartaric acid 0.01% by weight, glycolic acid 0.01% by weight, lactic acid 0.011% by weight /.)
• ヒアル口ン酸ナトリウム ' · · 0. 05重量0 /0 • hyaluronan opening sodium phosphate '- - 0.05 weight 0/0
そして、 A剤を顔に塗布し、 30秒以内にぬるま湯で洗顔したのち、 B剤を手 の平にとり、 皮膚を軽くパッティングするように塗布し、 B剤が馴染んだらその 上からさらに C剤を塗布するという手順を、 20才代 3名 (A〜C)、 30才代 5 名 (A〜E)、 40才代 9名 (A〜 I )、 50才代 5名 (A〜E)、 60才代 5名 (A Then, apply agent A to the face, wash the face with lukewarm water within 30 seconds, take agent B on the palm of your hand, apply lightly on the skin, and apply agent C after agent B is used. The procedure of application is 3 people in their 20s (A to C), 5 people in their 30s (A to E), 9 people in their 40s (A to I), 5 people in their 50s (A to E), 5 in the 60s (A
〜D) の計 26名の女性モニターにそれぞれ 1年間朝夕 2回実施してもらうとと もに、 各モニターの実施前、 1力月後、 6力月後、 12力月後の皮膚の状態をミ リシン樹脂によるレプリカ法を用いて評価した。 上記レプリカ法は、 肌のレプリカを採った後、 レプリカの表面を 1 7倍の顕微 鏡で観て、 以下の表 1に示すように 1〜 5の評点で段階分けした。 ~ D) for each of the 26 female monitors to conduct the test twice a morning and evening, and the skin condition before, 1 month, 6 months, and 12 months before each monitor Was evaluated by a replica method using a myricin resin. In the above-mentioned replica method, after taking a replica of the skin, the surface of the replica was observed with a microscope of 17 times magnification, and classified into 1 to 5 as shown in Table 1 below.
そして、 その結果を以下の表 2に示した。  The results are shown in Table 2 below.
【表 1】  【table 1】
【表 2】  [Table 2]
上記表 2から、 A剤、 B剤、 C剤の 3つの液剤からなる本発明の皮膚改善用耝 成物セットを用いるようにすれば、 年齢に関わらず、 使用 1力月でかなりの皮膚 改善効果がみられ、 1 2力月後にはほとんどの人が美しい肌になることがよくわ かる。  According to Table 2 above, if the composition for improving skin of the present invention comprising the three liquid preparations of A preparation, B preparation and C preparation is used, regardless of age, considerable skin improvement can be achieved in one month of use, regardless of age. The effect is seen, and it is clear that most people will have beautiful skin after 12 months.
なお、 本発明は、 上記の実施の形態および実施例に限定されるものではなく、 各組成物中にビタミン補給成分、 香料、 可溶化剤、 增粘剤、 保湿剤、 湿潤剤、 溶 剤等の通常の化粧料に配合される成分を有効成分の働きを阻害しない程度に適宜 添加できる。 勿論、 精製水で希釈されていることは言うまでもない。 産業上の利用可能性  It should be noted that the present invention is not limited to the above-described embodiments and examples, and that a vitamin supplement component, a fragrance, a solubilizer, a thickener, a humectant, a humectant, a solvent, and the like are contained in each composition. Ingredients to be added to ordinary cosmetics can be appropriately added to such an extent that the function of the active ingredient is not hindered. Of course, it goes without saying that it is diluted with purified water. Industrial applicability
本発明にかかる皮膚改善用組成物セットは、以上のように構成されているので、 o:—ヒドロキシ酸の含有濃度を高くしても違和感無く使用でき、 しかも、 皮膚を 傷めることなく新陳代謝機能を助け、 皮膚を美しくみずみずしい状態に保つこと ができる。 しかも、 a—ヒドロキシ酸の含有濃度を高くできるので、 改善効果が 高くなるとともに、 改善速度も速くなる。 Since the composition set for skin improvement according to the present invention is constituted as described above, it can be used without discomfort even if the concentration of o: -hydroxy acid is increased, and has a metabolic function without damaging the skin. Helps and keeps the skin beautiful and fresh. In addition, since the content of the a-hydroxy acid can be increased, the improvement effect is enhanced and the improvement speed is also increased.
【表 1】 【table 1】
占 評価 備考  Fortune evaluation Remarks
1 皮膚、 皮丘の消失、 広範囲の角層のめくれ ノ 1 れ  1 Elimination of skin and skin and suppuration of a wide range of stratum corneum
2 皮膚、 皮丘が不鮮明、 角層のめくれ 肌荒れ  2 Unclear skin and dull skin, turning of horny layer
3 皮膚、 皮丘は認められるが平坦 普通の肌 3 Skin and skin are visible but flat Normal skin
4 皮膚、 皮丘が鮮明 比較的美-しい肌4 Skin and skin are clear and relatively beautiful
5 皮膚、 皮丘が鮮明で整っている 美しい肌 5 Beautiful skin with clear and clean skin
【表 2】 [Table 2]
初期評点 1力月後 6力月後 1 2力月後 0才代 A 2 4 5 5  Initial score 1 month later 6 months later 1 2 months later 0s A2 4 5 5
0才代 B 3 3 4 5  0s B 3 3 4 5
0才代 C 4 5 5 5  0s C 4 5 5 5
0才代 A 1 2 4 4  0s A 1 2 4 4
0才代 B 1 3 4 4  0s B 1 3 4 4
0才代 C 2 4 5 5  0s C 2 4 5 5
0才代 D 3 4 5 5  0s D 3 4 5 5
0才代 E 3 5 5 5  0s E 3 5 5 5
0才代 A 1 3 4 5  0s A 1 3 4 5
0才代 B 2 3 3 4 ' 0才代 C 2 3 4 4  0s B2 3 3 4 '0s C2 3 4 4
0才代 D 2 4 5 5  0s D 2 4 5 5
0才代 E 3 4 4 5  0s E 3 4 4 5
0才代 F 3 4 5 5  0s F 3 4 5 5
0才代 G 3 4 5 5  0s G3 4 5 5
0才代 H 3 5 5 5  0s H 3 5 5 5
0才代 I 4 5 . 5 5  0s I 4 5.5 .5 5
0才代 A 2 3 3 4  0s A 2 3 3 4
0才代 B 2 3 4 5  0s B2 3 4 5
0才代 C 2 3 5 5  0s C 2 3 5 5
0才代 D 3 4 5 5  0s D 3 4 5 5
0才代 E 3 5 5 5  0s E 3 5 5 5
0才代 A 1 2 3 5  0s A 1 2 3 5
0才代 B 1 3 3 5  0s B 1 3 3 5
0才代 C 2 3 3 4  0s C2 3 3 4
0才代 D 2 3 4 5  0s D 2 3 4 5

Claims

請 求 の 範 囲 The scope of the claims
1 . 少なくとも 1種のアミノ酸と、 ヒアルロン酸塩と、 水溶性コラーゲンと、 グリチルリチン酸ジカリウムと、 アラントインと、 力 [I水分解エラスチン液と、 少 なくとも 1種の植物抽出エキスとを、 少なくともその有効成分として含む A剤、 少なくとも 1種の α—ヒドロキシ酸と、 アラントインと、 グリチルリチン酸ジカ リウムとを、 少なくともその有効成分として含む Β剤、 1. At least one amino acid, hyaluronic acid salt, water-soluble collagen, dipotassium glycyrrhizinate, allantoin, force [I hydrolyzed elastin solution, and at least one plant extract, Agent A containing as an active ingredient at least one α-hydroxy acid, allantoin, and dicarium glycyrrhizinate as an active ingredient
セラミドと、 少なくとも 1種の植物エキスとを、 少なくともその有効成分として 含む C剤、  C agent comprising ceramide and at least one plant extract at least as active ingredients thereof,
の 3つの糸且成物からなる皮膚改善用組成物セット。  A skin-improving composition set comprising the three yarns.
2 . Α剤中のアミノ酸が、 グリシン、 ァラニン、 プロリン、 セリン、 スレオニ0 ン、 アルギニン、 リジン、 グルタミン酸からなる群より選ばれた少なくとも 1種 である請求の範囲第 1項に記載の皮膚改善用組成物セット。 2. The skin-improving skin according to claim 1, wherein the amino acid in the preparation is at least one selected from the group consisting of glycine, alanine, proline, serine, threonine, arginine, lysine, and glutamic acid. Composition set.
3 . A剤中の植物抽出エキスが、 ォゥゴンエキス、 センブリエキス、 アロエェ キス、 力モミラエキス、 オトギリソゥエキス、 シナノキエキス、 トウキンセン力 エキスャグノレマソウエキス、 ローマ力ミツレエキス、 ァ /レカニ力エキス、 / リエ^ タエキス、 キューカンバエキス、 セィユキズタエキス、 ゼニァ才イエキス、 セィ ヨウニヮトコエキス、 マツリ力エキス、 ドクダミエキス、 甘草エキス、 マロニエ エキス、 コゥゾエキス、 サノレビアエキス、 三色スミレエキス、 スギナエキス力 ら なる群より選ばれた少なくとも 1種である請求の範囲第 1項または請求の範囲第 2項に記載の皮膚改善用組成物セット。 03. The plant extract in Agent A is ozone extract, assemblage extract, aloe kiss, potato millet extract, otogirisou extract, linden extract, tokinsen power extract yagnoremasou extract, roma power beetle extract, a / recani power extract, / rie ^ Consisting of extract of extract, cucumber, extract of squid, extract of senna, extract of saccharomyces cinnamon, extract of matsuri force, dokudami extract, licorice extract, malonie extract, kozzo extract, sanorevia extract, tricolor violet extract, and horsetail extract power 3. The composition set for improving skin according to claim 1, which is at least one member selected from the group. 0
4 . α—ヒドロキシ酸が、 コハク酸、 リンゴ酸、 クェン酸、 し酸、 グリコール 酸、 酒石酸からなる群より選ばれた少なくとも 1種である請求の範囲第 1項〜第 3項のいずれかに記載の皮膚改善用組成物セット。 4. The method according to any one of claims 1 to 3, wherein the α-hydroxy acid is at least one selected from the group consisting of succinic acid, malic acid, citric acid, citric acid, glycolic acid, and tartaric acid. The composition set for skin improvement according to the above.
5 . B剤中および C剤の植物抽出エキスが、 ダイズエキス、 甘草エキス、 クヮ エキス、 チヤエキス、 内豆エキス、 ユキノシタエキス、 ゥワウ/レシ流エキス、 ォ ゥゴンエキス、 チヤエキスからなる群より選ばれた少なくとも 1種である請求の 範囲第 1項〜第 4項のいずれかに記載の皮膚改善用組成物セット。 5. The plant extract in the B agent and the C agent is at least one selected from the group consisting of soybean extract, licorice extract, mulberry extract, cherries extract, endosperm extract, saxifrage extract, ゥ owa / resi flow extract, ゥ gonex extract, and cherries extract. The set for improving skin according to any one of claims 1 to 4, which is a seed.
6 . C剤力、 植物抽出エキスとして甘草エキスおよびチヤエキスを少なくとも 含む請求の範囲第 1項〜第 5項のいずれかに記載の皮膚改養用組成物セット。 6. The composition for skin remediation according to any one of claims 1 to 5, comprising at least a C agent power and at least a licorice extract and a ginger extract as plant extracts.
PCT/JP2001/001595 2001-03-01 2001-03-01 Skin-improving composition set WO2002069913A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2002569091A JPWO2002069913A1 (en) 2001-03-01 2001-03-01 Composition set for skin improvement
PCT/JP2001/001595 WO2002069913A1 (en) 2001-03-01 2001-03-01 Skin-improving composition set

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2001/001595 WO2002069913A1 (en) 2001-03-01 2001-03-01 Skin-improving composition set

Publications (1)

Publication Number Publication Date
WO2002069913A1 true WO2002069913A1 (en) 2002-09-12

Family

ID=11737087

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/001595 WO2002069913A1 (en) 2001-03-01 2001-03-01 Skin-improving composition set

Country Status (2)

Country Link
JP (1) JPWO2002069913A1 (en)
WO (1) WO2002069913A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004203855A (en) * 2002-06-24 2004-07-22 Akira Awaya Prophylactic and therapeutic method for allergic rhinitis/conjunctivitis, skin allergy and atopic dermatitis
WO2007004300A1 (en) * 2005-07-06 2007-01-11 Dr.Ci:Labo Co., Ltd. Cosmetic product
JP2008056570A (en) * 2006-08-29 2008-03-13 Fujifilm Corp External preparation for skin
US7399464B2 (en) 2001-06-11 2008-07-15 Genodyssee Sa Polypeptides of the IFNα-7 gene

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508324A2 (en) * 1991-04-10 1992-10-14 Ruey J. Dr. Yu Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
JPH07223934A (en) * 1994-02-14 1995-08-22 Kanebo Ltd Cosmetic for skin
JPH07242529A (en) * 1994-03-03 1995-09-19 Kanebo Ltd Skin cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508324A2 (en) * 1991-04-10 1992-10-14 Ruey J. Dr. Yu Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
JPH07223934A (en) * 1994-02-14 1995-08-22 Kanebo Ltd Cosmetic for skin
JPH07242529A (en) * 1994-03-03 1995-09-19 Kanebo Ltd Skin cosmetic

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399464B2 (en) 2001-06-11 2008-07-15 Genodyssee Sa Polypeptides of the IFNα-7 gene
JP2004203855A (en) * 2002-06-24 2004-07-22 Akira Awaya Prophylactic and therapeutic method for allergic rhinitis/conjunctivitis, skin allergy and atopic dermatitis
JP4721626B2 (en) * 2002-06-24 2011-07-13 昭 粟屋 Prevention and treatment of allergic rhinitis / conjunctivitis or skin allergy and atopic dermatitis
WO2007004300A1 (en) * 2005-07-06 2007-01-11 Dr.Ci:Labo Co., Ltd. Cosmetic product
JPWO2007004300A1 (en) * 2005-07-06 2009-01-22 株式会社ドクターシーラボ Cosmetics
JP2008056570A (en) * 2006-08-29 2008-03-13 Fujifilm Corp External preparation for skin

Also Published As

Publication number Publication date
JPWO2002069913A1 (en) 2004-09-09

Similar Documents

Publication Publication Date Title
TWI352595B (en) Cosmetic and cosmeceutical compositions for restor
US20080183250A1 (en) Compositions and methods for treating or preventing skin inflammation via restoration of skin barrier function
JP2005534691A (en) Cosmetic or dermopharmaceutical composition comprising kombucha
JP2016166236A (en) Wrinkle improving composition comprising placenta derived component
JP2002053428A (en) Skin care preparation
EP2051690B1 (en) Use of c-glycoside derivatives as pro-desquamating active agents
WO2016065688A1 (en) Essence capable of activating skin vitality and being anti-aging
CN113332160A (en) Cosmetic composition for conditioning peritrichotic skin
KR20220114509A (en) Cleansing agent composition and cleanser prepared thereby
WO2010140724A1 (en) Perm composition
CN107468610A (en) A kind of extraction product of rice bran shell and its application in facial-care
JP5084831B2 (en) Cosmetic composition for exfoliating skin
JP3928746B2 (en) Skin cosmetics
WO2002058640A1 (en) Topical therapeutic skin care system
JP2008088105A (en) Cosmetic for skin or hair
WO2002069913A1 (en) Skin-improving composition set
RU2671511C1 (en) Cosmetic composition for hair and head skin care (options)
CN115887264A (en) Liponic acid combined fullerene liposome, essence and preparation method thereof
KR100558751B1 (en) Cosmetic composition for skin miosture
CN109453076A (en) A kind of face cleaning containing ferment admires silk and preparation method thereof
CN115337243A (en) Blackhead removing composition and cosmetic
JP2009234986A (en) Skin external preparation containing synergistic effect water
KR20010090063A (en) Mud omitted
CN112587431A (en) Brown sugar scrub cream and preparation method thereof
EP1401418B1 (en) Topical treatments using alkanolamines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2002569091

Country of ref document: JP

122 Ep: pct application non-entry in european phase